Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate

Acta Derm Venereol. 2003;83(5):391-2. doi: 10.1080/00015550310012593.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Erythema / chemically induced*
  • Erythema / drug therapy
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Piperazines / adverse effects*
  • Pityriasis / chemically induced*
  • Pityriasis / drug therapy
  • Pyrimidines / adverse effects*

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Methylprednisolone